Fennec Pharmaceuticals (FENC) Other Non Operating Income (2010 - 2026)

Fennec Pharmaceuticals (FENC) has 16 years of Other Non Operating Income data on file, last reported at -$2.0 million in Q4 2025.

• Quarterly Other Non Operating Income fell 7488.89% year-over-year to -$2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (down 2365.85% YoY) and the FY2025 annual result came in at -$2.0 million, down 2365.85% from the prior year.
• Other Non Operating Income eased to -$2.0 million in Q4 2025, from -$3000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $17000.0 in Q2 2025 to a low of -$2.0 million in Q4 2025.
• A 5-year average of -$111473.7 and a median of -$3000.0 in 2022 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2023 — Other Non Operating Income soared 400.0% — and 2025, when it slumped 7488.89%.
• Tracing FENC's Other Non Operating Income over 5 years: stood at -$1000.0 in 2021, then slumped by 200.0% to -$3000.0 in 2022, then surged by 166.67% to $2000.0 in 2023, then plunged by 1450.0% to -$27000.0 in 2024, then tumbled by 7488.89% to -$2.0 million in 2025.
• The last three Other Non Operating Income figures came in at -$2.0 million (Q4 2025), -$3000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.